TENEDOSE M

MRP

107.7/Strip

Description

• Each uncoated bilayered tablet contains : Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg (In Extended Release Form)

Doses

• As Directed by Physician

Indication

• This combination belongs to the group of medications called ‘antidiabetic agents’ used to treat type 2 diabetes mellitus. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes.